Flow MedTech focuses on advancing medical innovations to provide improved quality of care and save lives.


Stroke Prevention for Atrial Fibrillation Patients

Flow MedTech International Corp. has developed a proprietary medical device and method of delivery for stroke reduction in patients who suffer from Atrial Fibrillation (AF) through left atrial appendage (LAA) closure. Based on peer-reviewed scientific research, 90% of clots in the brain have been found to originate from the LAA, and AF patients suffer from a five-fold increase in their risk of stroke.

Devices

Investors

Team


Latest News


Testimonials

No Thumbnail

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s. Lorem Ipsum is simply dummy text of the printing and typesetting industry.

First Testimonial

No Thumbnail

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s. Lorem Ipsum is simply dummy text of the printing and typesetting industry.

Second Testimonial

No Thumbnail

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s. Lorem Ipsum is simply dummy text of the printing and typesetting industry.

Third Testimonial